Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.
-
Upload
melinda-owens -
Category
Documents
-
view
222 -
download
2
Transcript of Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.
![Page 1: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/1.jpg)
Dr.Toba kazemiAssociate Professor of Cardiology
BUMS-BCRC24Farvardin 1391Harisson 2012 1983-1991
![Page 2: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/2.jpg)
IntroductionIntroduction::
Disease of blood vessels – large arteries.Disease of blood vessels – large arteries. Modern life style disease… *Modern life style disease… * Major cause of IHD, MI, Stroke & Aortic Major cause of IHD, MI, Stroke & Aortic
disease - Major cause of death & disability.disease - Major cause of death & disability. Incidence is decreasing since 1995 - WestIncidence is decreasing since 1995 - West Better understanding & Change in life style. Better understanding & Change in life style.
![Page 3: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/3.jpg)
DefinitionDefinition::
““Chronic inflammatory disorder of Chronic inflammatory disorder of intimaintima of of largelarge arteriesarteries characterised characterised
by formation of fibrofatty plaques by formation of fibrofatty plaques called atheromacalled atheroma.”.”
Hardening of arteries - ArteriosclerosisHardening of arteries - Arteriosclerosis
![Page 4: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/4.jpg)
EtiologyEtiology::
Exact cause is unknownExact cause is unknown Variation in severity & distribution.Variation in severity & distribution. Starts with endothelial injury.Starts with endothelial injury. Genetic/Familial Genetic/Familial Risk Factors… Risk Factors…
Age, Htn, DM, Smoking – endothelial damage.Age, Htn, DM, Smoking – endothelial damage. Obesity, lifestyle, economic status, - lipid.Obesity, lifestyle, economic status, - lipid. Activation of Platelet / Coagulation.Activation of Platelet / Coagulation.
Oxidised LDL.Oxidised LDL.
![Page 5: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/5.jpg)
Lipoprotiens - LDL & HDLLipoprotiens - LDL & HDL
• Good and Bad Fats?• Lower LDL, Increase HDL• Mono unsaturated fats• Poly unsaturated fats• Omega-3 fatty acids (Fish)• LDL indicate Positive lipid
balance, HDL – negative.
![Page 6: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/6.jpg)
Risk FactorsRisk Factors::
Non modifiableNon modifiable AgeAge Male Sex, Male Sex, Genetic - Hyperchol. Genetic - Hyperchol. Family historyFamily history
Potentially ModifiablePotentially Modifiable Hyperlipidemia – Hyperlipidemia –
HDL/LDL ratio.HDL/LDL ratio. Hypertension.Hypertension. Smoking.Smoking. Diabetes.Diabetes.
![Page 7: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/7.jpg)
PathogenesisPathogenesis:: intimal injuryintimal injury Inflammation, NecrosisInflammation, Necrosis Lipid – Cholesterol accumulation (soft.a)Lipid – Cholesterol accumulation (soft.a) Fibrosis, smooth muscle proliferation (hard.a)Fibrosis, smooth muscle proliferation (hard.a) Extension of lesion and destruction of vesselExtension of lesion and destruction of vessel Complications - Thrombosis, embolism, Complications - Thrombosis, embolism,
aneurism, dissection & rupture.aneurism, dissection & rupture.
![Page 8: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/8.jpg)
Structure of AtheromaStructure of Atheroma::
Fibrous Cap
Necrotic center
Cholesterol Cry.
Macrophages
![Page 9: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/9.jpg)
Pathogenesis-stagesPathogenesis-stages
Type I – Fatty dots - Foam cellsType I – Fatty dots - Foam cells Type II – Fatty streakType II – Fatty streak Type III – Extracellular lipid poolType III – Extracellular lipid pool Type IV – Atheroma – Core of lipidType IV – Atheroma – Core of lipid Type V – Fibroatheroma – Fibrotic layerType V – Fibroatheroma – Fibrotic layer Type VI – Complicated – Ulcer, Ca+Type VI – Complicated – Ulcer, Ca+
Hemorrhage, thrombus, embolism, aneurysm.Hemorrhage, thrombus, embolism, aneurysm.
![Page 10: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/10.jpg)
Development of Development of Coronary AtherosclerosisCoronary Atherosclerosis::
![Page 11: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/11.jpg)
ComplicationsComplications::
Thrombosis, Thrombo-embolismThrombosis, Thrombo-embolism Rupture – HaemorrhageRupture – Haemorrhage AneurysmAneurysm Fibrosis & CalcificationFibrosis & Calcification Ischemia / Infarction – end organ damage.Ischemia / Infarction – end organ damage. Stroke, Myocardial Infarctions, Renal Stroke, Myocardial Infarctions, Renal
infarction, Mesentric vein thrombosis, infarction, Mesentric vein thrombosis, intermittent claudication, gangrene etc. intermittent claudication, gangrene etc.
![Page 12: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/12.jpg)
Coronary AtheorsclerosisCoronary Atheorsclerosis
•Left Coronary Artery.•Anterior Descending (LAD)•Left Circumflex (LCx)
•Right Coronary Artery.
LCx
LAD
![Page 13: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/13.jpg)
Coronary Coronary Thrombosis Thrombosis
With InfarctionWith Infarction
![Page 14: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/14.jpg)
Coronary AngioplastyCoronary Angioplasty::
![Page 15: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/15.jpg)
![Page 16: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/16.jpg)
![Page 17: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/17.jpg)
![Page 18: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/18.jpg)
Atheroma - Objectives 1Atheroma - Objectives 1
Definition of atheromaDefinition of atheromaMacroscopic appearancesMacroscopic appearancesMicroscopic appearancesMicroscopic appearancesEffectsEffects
![Page 19: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/19.jpg)
AtheromaAtheroma
DefinitionDefinition
Atheroma is the accumulation of Atheroma is the accumulation of intracellular and extracellular lipid in the intracellular and extracellular lipid in the intima of large and medium sized arteriesintima of large and medium sized arteries
![Page 20: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/20.jpg)
AtherosclerosisAtherosclerosis
DefinitionDefinition
The thickening and hardening of arterial The thickening and hardening of arterial walls as a consequence of atheromawalls as a consequence of atheroma
The thickening of the walls of arteries and The thickening of the walls of arteries and arterioles usually as a result of arterioles usually as a result of hypertension or diabetes mellitushypertension or diabetes mellitus
![Page 21: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/21.jpg)
Atheroma - Macroscopic Atheroma - Macroscopic FeaturesFeatures
Fatty streakFatty streak Simple plaqueSimple plaque Complicated plaqueComplicated plaque
![Page 22: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/22.jpg)
Atheroma - The Fatty StreakAtheroma - The Fatty Streak
Lipid deposits in Lipid deposits in intimaintima
Yellow, slightly Yellow, slightly raisedraised
![Page 23: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/23.jpg)
Atheroma - The Simple Atheroma - The Simple PlaquePlaque
Raised yellow/whiteRaised yellow/white Irregular outlineIrregular outline Widely distributedWidely distributed Enlarge and Enlarge and
coalescecoalesce
![Page 24: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/24.jpg)
Atheroma - The Complicated Atheroma - The Complicated PlaquePlaque
ThrombosisThrombosis Haemorrhage into Haemorrhage into
plaqueplaque CalcificationCalcification Aneurysm formationAneurysm formation
![Page 25: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/25.jpg)
Atheroma - Common SitesAtheroma - Common Sites
Aorta - especially abdominalAorta - especially abdominal Coronary arteriesCoronary arteries Carotid arteriesCarotid arteries Cerebral arteriesCerebral arteries Leg arteriesLeg arteries
![Page 26: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/26.jpg)
Normal Arterial StructureNormal Arterial Structure
EndotheliumEndothelium Sub-endothelial c.t.Sub-endothelial c.t. Internal elastic Internal elastic
laminalamina Muscular mediaMuscular media External elastic External elastic
laminalamina AdventitiaAdventitia
![Page 27: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/27.jpg)
Atheroma - Microscopic Atheroma - Microscopic FeaturesFeatures
Early changesEarly changes proliferation of smooth muscle cellsproliferation of smooth muscle cells accumulation of foam cellsaccumulation of foam cells extracellular lipidextracellular lipid
EndotheliumEndothelium
Smooth muscle cellSmooth muscle cell
LipidLipid
MatrixMatrix
![Page 28: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/28.jpg)
Atheroma - Microscopic Atheroma - Microscopic FeaturesFeatures
Later changesLater changes fibrosisfibrosis necrosisnecrosis cholesterol cleftscholesterol clefts +/- inflammatory cells+/- inflammatory cells
![Page 29: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/29.jpg)
Atheroma - Microscopic Atheroma - Microscopic FeaturesFeatures
Later changesLater changes disruption of internal elastic laminadisruption of internal elastic lamina damage extends into mediadamage extends into media ingrowth of blood vesselsingrowth of blood vessels plaque fissuringplaque fissuring
![Page 30: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/30.jpg)
Atheroma - Coronary ArteryAtheroma - Coronary Artery
![Page 31: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/31.jpg)
Atheroma - Clinical EffectsAtheroma - Clinical Effects
Ischaemic heart diseaseIschaemic heart disease sudden deathsudden death myocardial infarctionmyocardial infarction angina pectorisangina pectoris arrhythmiasarrhythmias cardiac failurecardiac failure
![Page 32: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/32.jpg)
Atheroma – cerebral infarctionAtheroma – cerebral infarction
![Page 33: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/33.jpg)
Atheroma – Abdominal Aortic Atheroma – Abdominal Aortic AneurysmAneurysm
![Page 34: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/34.jpg)
Atheroma - PathogenesisAtheroma - Pathogenesis
AgeAge GenderGender HyperlipidaemiaHyperlipidaemia Cigarette smokingCigarette smoking HypertensionHypertension Diabetes mellitusDiabetes mellitus InfectionInfection
![Page 35: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/35.jpg)
AtheromaAtheroma
AgeAge slowly progressive throughout adult lifeslowly progressive throughout adult life risk factors operate over yearsrisk factors operate over years
GenderGender women protected relatively before women protected relatively before
menopausemenopause presumed hormonal basispresumed hormonal basis
![Page 36: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/36.jpg)
AtheromaAtheroma
HyperlipidaemiaHyperlipidaemia high plasma cholesterol associated with high plasma cholesterol associated with
atheromaatheroma LDL most significantLDL most significant HDL protectiveHDL protective
![Page 37: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/37.jpg)
Atheroma-InfectionAtheroma-Infection
Chlamydia pneumoniaeChlamydia pneumoniae Helicobacter pyloriHelicobacter pylori CytomegalovirusCytomegalovirus
![Page 38: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/38.jpg)
Atheroma - Other Risk FactorsAtheroma - Other Risk Factors
Lack of exerciseLack of exercise ObesityObesity StressStress Familial predisposition well knownFamilial predisposition well known
![Page 39: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/39.jpg)
Atheroma - PathogenesisAtheroma - Pathogenesis
Thrombogenic theoryThrombogenic theory Insudation theoryInsudation theory Monoclonal hypothesisMonoclonal hypothesis Reaction to injury hypothesisReaction to injury hypothesis
![Page 40: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/40.jpg)
Atheroma - Thrombogenic Atheroma - Thrombogenic TheoryTheory
1852 Karl Rokitansky1852 Karl Rokitansky plaques formed by plaques formed by
repeated thrombirepeated thrombi lipid derived from lipid derived from
thrombithrombi overlying fibrous capoverlying fibrous cap
![Page 41: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/41.jpg)
Atheroma - Insudation TheoryAtheroma - Insudation Theory
1856 Rudolf 1856 Rudolf VirchowVirchow endothelial injuryendothelial injury inflammationinflammation increased increased
permeability to permeability to lipid from plasmalipid from plasma
![Page 42: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/42.jpg)
Atheroma - Reaction to Injury Atheroma - Reaction to Injury HypothesisHypothesis
1972 Ross and Glomset1972 Ross and Glomset plaques form in response to endothelial injuryplaques form in response to endothelial injury hypercholesterolaemia leads to endothelial hypercholesterolaemia leads to endothelial
damage in experimental animalsdamage in experimental animals injury increases permeability and allows injury increases permeability and allows
platelet adhesionplatelet adhesion monocytes penetrate endotheliummonocytes penetrate endothelium smooth muscle cells proliferate and migratesmooth muscle cells proliferate and migrate
![Page 43: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/43.jpg)
Atheroma - Reaction to Injury Atheroma - Reaction to Injury HypothesisHypothesis
1986 Ross1986 Ross endothelial injury may be very subtle and endothelial injury may be very subtle and
be undetectable visuallybe undetectable visually LDL, especially oxidised, may damage LDL, especially oxidised, may damage
endotheliumendothelium
![Page 44: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/44.jpg)
Atheroma - The Monoclonal Atheroma - The Monoclonal HypothesisHypothesis
Benditt and BendittBenditt and Benditt crucial role for smooth muscle proliferationcrucial role for smooth muscle proliferation each plaque is monoclonaleach plaque is monoclonal might represent abnormal growth controlmight represent abnormal growth control is each plaque a benign tumour?is each plaque a benign tumour? could atheroma have a viral aetiology?could atheroma have a viral aetiology?
![Page 45: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/45.jpg)
Atheroma - The Processes Atheroma - The Processes InvolvedInvolved
ThrombosisThrombosis Lipid accumulationLipid accumulation Production of intercellular matrixProduction of intercellular matrix Interactions between cell typesInteractions between cell types
![Page 46: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/46.jpg)
Atheroma - The Cells InvolvedAtheroma - The Cells Involved
Endothelial cellsEndothelial cells PlateletsPlatelets Smooth muscle cellsSmooth muscle cells MacrophagesMacrophages LymphocytesLymphocytes NeutrophilsNeutrophils
![Page 47: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/47.jpg)
Atheroma - A Unifying Atheroma - A Unifying Hypothesis 1Hypothesis 1
Endothelial injury due toEndothelial injury due to raised LDLraised LDL ‘‘toxins’ eg cigarette smoketoxins’ eg cigarette smoke hypertensionhypertension haemodynamic stresshaemodynamic stress
Endothelial injury causesEndothelial injury causes platelet adhesion, PDGF release, SMC proliferation platelet adhesion, PDGF release, SMC proliferation
and migrationand migration insudation of lipid, LDL oxidation, uptake of lipid by insudation of lipid, LDL oxidation, uptake of lipid by
SMC and macrophagesSMC and macrophages migration of monocytes into intimamigration of monocytes into intima
![Page 48: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/48.jpg)
Atheroma - A Unifying Atheroma - A Unifying Hypothesis 3Hypothesis 3
Stimulated SMC produce matrix materialStimulated SMC produce matrix material Foam cells secrete cytokines causingFoam cells secrete cytokines causing
further SMC stimulationfurther SMC stimulation recruitment of other inflammatory cellsrecruitment of other inflammatory cells
![Page 49: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/49.jpg)
Atheroma - PreventionAtheroma - Prevention
No smokingNo smoking Reduce fat intake Reduce fat intake Treat hypertensionTreat hypertension Not too much alcoholNot too much alcohol Regular exercise/weight controlRegular exercise/weight control
BUT some people will still develop BUT some people will still develop atheroma!atheroma!
![Page 50: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/50.jpg)
Atheroma - InterventionAtheroma - Intervention
Stop smokingStop smoking Modify dietModify diet Treat hypertensionTreat hypertension Treat diabetesTreat diabetes Lipid lowering drugsLipid lowering drugs
![Page 51: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/51.jpg)
pathogenesispathogenesis
Atherosclerosis: major cause of death & Atherosclerosis: major cause of death & premature disability in developed societypremature disability in developed society
By 2020 :CVD is the leading global cause By 2020 :CVD is the leading global cause of total disease burdenof total disease burden
Atherosclerosis affect various region of Atherosclerosis affect various region of circulation: although its risk factors are circulation: although its risk factors are systemic or generalizedsystemic or generalized
![Page 52: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/52.jpg)
pathogenesispathogenesis
Atherosclerosis of coronary A. :MI, angina Atherosclerosis of coronary A. :MI, angina pectorispectoris
Atherosclerosis of CNS:TIA , strokeAtherosclerosis of CNS:TIA , stroke Atherosclerosis of peripheral A : intermittent Atherosclerosis of peripheral A : intermittent
claudication ,gangreneclaudication ,gangrene Atherosclerosis of splanchnic circulation;. Atherosclerosis of splanchnic circulation;.
Mesentric ischemiaMesentric ischemia Atherosclerosis of kidney:renal art. Atherosclerosis of kidney:renal art.
Stenosis, emboli to Renal A.Stenosis, emboli to Renal A.
![Page 53: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/53.jpg)
5353
THROMBOSIS ORTHROMBOSIS OR EMBOLISM ON ULCERED PLAQUEEMBOLISM ON ULCERED PLAQUE
ISCHEMIC INFARCTIONISCHEMIC INFARCTION
CEREBRAL FORM OF ATHEROSCLEROSISCEREBRAL FORM OF ATHEROSCLEROSIS
HemorrhageHemorrhage within withinThe brainThe brain
![Page 54: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/54.jpg)
5454
RENAL FORM OF RENAL FORM OF ATHEROSCLEROSISATHEROSCLEROSIS
Acute form may be as Acute form may be as infarctioninfarction
Chronic form is calledChronic form is calledAtheroscleroticAtheroscleroticNephrosclerosis orNephrosclerosis orPrimary contractedPrimary contractedkidneykidney
![Page 55: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/55.jpg)
5555
Intestinal form of atherosclerosisIntestinal form of atherosclerosis
Acute form may be as Acute form may be as gangrenous necrosis gangrenous necrosis of the intestineof the intestine
Chronic form may be Chronic form may be as ischemic as ischemic enterocolitisenterocolitis
![Page 56: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/56.jpg)
5656
Extremity form of atherosclerosisExtremity form of atherosclerosis
Acute form may be as gangrenous Acute form may be as gangrenous necrosis.necrosis.
![Page 57: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/57.jpg)
atherosclerosis in arterial bedatherosclerosis in arterial bed Occur focallyOccur focally At branching point: disturbed blood flowAt branching point: disturbed blood flow coronary A. :proximal of LADcoronary A. :proximal of LAD Atherosclerosis renal artery: proximal portionAtherosclerosis renal artery: proximal portion Extra cranial circulation: carotid bifurcationExtra cranial circulation: carotid bifurcation Not always stenotic: ectasia, aneurysmNot always stenotic: ectasia, aneurysm Nonocclosive diffuse intimal irregularity :IVUS , Nonocclosive diffuse intimal irregularity :IVUS ,
postmortempostmortem
![Page 58: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/58.jpg)
Atherosclerosis in human: occure over a Atherosclerosis in human: occure over a period( years / decades)period( years / decades)
Growth of Atherosclerosis:not smooth or Growth of Atherosclerosis:not smooth or linear / but quiesencelinear / but quiesence
rapid evolutionrapid evolution
chronic:chronic:
clinically expression of AT acute: AMI clinically expression of AT acute: AMI ,SCD,stroke,SCD,stroke
never experience never experience clinical manifestation clinical manifestation
![Page 59: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/59.jpg)
![Page 60: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/60.jpg)
6060
Pathogenesis ofPathogenesis of AtherosclerosisAtherosclerosis
According to injury hypothesis According to injury hypothesis considers atherosclerosis to be a considers atherosclerosis to be a chronic inflammatory Response of chronic inflammatory Response of the arterial wall initiated by injury:the arterial wall initiated by injury:
![Page 61: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/61.jpg)
6161
Pathogenesis ofPathogenesis of AtherosclerosisAtherosclerosis
1 1 chronic endothelial injurychronic endothelial injury2 insudation of lipoproteins [LDL]2 insudation of lipoproteins [LDL]3 modification of lipoproteins by 3 modification of lipoproteins by
oxidationoxidation4 adhesion of blood monocytes4 adhesion of blood monocytes5 adhesion of platelets5 adhesion of platelets
![Page 62: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/62.jpg)
6262
Pathogenesis ofPathogenesis of AtherosclerosisAtherosclerosis
6 migration of smooth muscle cells6 migration of smooth muscle cells
from the media into the intimafrom the media into the intima
7 proliferation of smooth muscle cells7 proliferation of smooth muscle cells
in the intimain the intima
8 enhanced accumulation of intra and8 enhanced accumulation of intra and
extra cellular lipids extra cellular lipids
![Page 63: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/63.jpg)
6363
atherosclerotic plaqueatherosclerotic plaque
It has three principle components:It has three principle components: 1 cells –smooth muscle cells, macrophages1 cells –smooth muscle cells, macrophages
other leukocytesother leukocytes
2 Extra cellular matrix- collagen, elastic fibers,2 Extra cellular matrix- collagen, elastic fibers,
proteoglycansproteoglycans
3 Intra cellular and extra cellular lipids3 Intra cellular and extra cellular lipids
![Page 64: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/64.jpg)
6464
There are two types of atherosclerotic There are two types of atherosclerotic plaque plaque
1 vulnerable 1 vulnerable 2 stable2 stable
atherosclerotic plaqueatherosclerotic plaque
![Page 65: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/65.jpg)
6565
atherosclerotic plaqueatherosclerotic plaque
1 vulnerable 2 STABLE1 vulnerable 2 STABLE
THERE ARETHERE ARE A LOT OF LIPIDSA LOT OF LIPIDS
![Page 66: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/66.jpg)
PathogenesisPathogenesis
Fatty streak: initial lesionFatty streak: initial lesion Mechanism: lipoprotein in intima (not simply Mechanism: lipoprotein in intima (not simply
from permeability or leakiness )from permeability or leakiness ) Lipoprotein bind to extracellular matrix Lipoprotein bind to extracellular matrix
(glycoseaminoglycans ) residence time (glycoseaminoglycans ) residence time of lipid rich particle= slow regress of this particleof lipid rich particle= slow regress of this particle
Oxidative modification of lipoproteinsOxidative modification of lipoproteins
![Page 67: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/67.jpg)
Chronic Chronic inflammatoryinflammatory response of the vascular response of the vascular wall to endothelial injury or dysfunctionwall to endothelial injury or dysfunction
Elevated plasma LDL levels causing the deposit Elevated plasma LDL levels causing the deposit of LDL in the subendothelium of blood vesselsof LDL in the subendothelium of blood vessels
Oxidation of transmigrated LDLOxidation of transmigrated LDL Activation of endothelial cellsActivation of endothelial cells Recruitment of monocytes/macrophages which Recruitment of monocytes/macrophages which
ingest oxLDL through scavenger receptorsingest oxLDL through scavenger receptors Formation of foam cells – fatty streaksFormation of foam cells – fatty streaks Proliferation of smooth muscle cellsProliferation of smooth muscle cells Deposition of extracellular matrix proteinsDeposition of extracellular matrix proteins
![Page 68: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/68.jpg)
Monocyte RecruitmentMonocyte Recruitment
intima
lumen LDL
![Page 69: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/69.jpg)
Lipid Core
lumen
neointima
Formation of Atherosclerotic PlaquesFormation of Atherosclerotic Plaques
![Page 70: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/70.jpg)
Plaque Rupture and ThrombosisPlaque Rupture and Thrombosis
Lipid Core
Tissue Factor Platelet Aggregation
![Page 71: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/71.jpg)
Atherosclerosis is the buildup of plaque on Atherosclerosis is the buildup of plaque on the inside walls of arteries. Plaque is made the inside walls of arteries. Plaque is made up of low density lipoprotein (up of low density lipoprotein (LDLLDL), ), macrophagesmacrophages, , smooth muscle cellssmooth muscle cells, platelets, , platelets, and other substances. It may narrow the and other substances. It may narrow the lumen of a blood vessel and restrict blood lumen of a blood vessel and restrict blood flow. Plaque rupture can induce the formation flow. Plaque rupture can induce the formation of thrombus (blood clot) and block blood flow. of thrombus (blood clot) and block blood flow. This will result in ischemic stroke or heart This will result in ischemic stroke or heart attack. attack.
![Page 72: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/72.jpg)
Formation of foam cellsFormation of foam cells
The first stage in the development of The first stage in the development of atherosclerosis is the formation of atherosclerosis is the formation of foam cellsfoam cells (macrophages with ingested oxidized LDL). The (macrophages with ingested oxidized LDL). The process begins with trap of LDL in the process begins with trap of LDL in the intimaintima, , which lies just below the endothelium (the which lies just below the endothelium (the monolayer of cells lining the arterial wall). monolayer of cells lining the arterial wall). Trapped LDL could be oxidized, triggering Trapped LDL could be oxidized, triggering recruitment of monocytes into the intima. recruitment of monocytes into the intima. Several adhesion molecules are involved, Several adhesion molecules are involved, including vascular-cell adhesion molecule including vascular-cell adhesion molecule (VCAM), integrin, selectin, and others. After (VCAM), integrin, selectin, and others. After entering the intima, monocytes differentiate into entering the intima, monocytes differentiate into macrophages and ingest oxidized LDL. macrophages and ingest oxidized LDL.
![Page 73: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/73.jpg)
Formation of plaqueFormation of plaque
As atherosclerosis progresses, T As atherosclerosis progresses, T lymphocytes, platelets and smooth muscle lymphocytes, platelets and smooth muscle cells also join foam cells, expanding the cells also join foam cells, expanding the plaque size. This involves cytokines to plaque size. This involves cytokines to activate T lymphocytes and growth factors to activate T lymphocytes and growth factors to promote proliferation of smooth muscle cells. promote proliferation of smooth muscle cells. Platelets can also release cytokines and Platelets can also release cytokines and growth factors to enhance migration and growth factors to enhance migration and proliferation of smooth muscle cells. During proliferation of smooth muscle cells. During this stage, a fibrous cap is formed to this stage, a fibrous cap is formed to separate the plaque from the lumenseparate the plaque from the lumen
![Page 74: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/74.jpg)
ThrombosisThrombosis
Thrombosis (formation of thrombus) arises Thrombosis (formation of thrombus) arises from plaque rupture. Macrophages may from plaque rupture. Macrophages may release metalloproteinases and other release metalloproteinases and other proteolytic enzymes to degrade fibrous proteolytic enzymes to degrade fibrous cap, making it susceptible to rupture. cap, making it susceptible to rupture. Plaque rupture activates platelets, leading Plaque rupture activates platelets, leading to formation of blood clots at the site of to formation of blood clots at the site of lesionlesion
![Page 75: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/75.jpg)
NONO((
Molecular mechanisms for the production Molecular mechanisms for the production of nitric oxide (NO) by exercise leading to of nitric oxide (NO) by exercise leading to the protection of atherosclerosis.the protection of atherosclerosis.
![Page 76: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/76.jpg)
![Page 77: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/77.jpg)
Emerging anti-inflammatory therapies in clinical atherosclerosis.
Klingenberg R , Hansson G K Eur Heart J 2009;30:2838-2844
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: [email protected]
![Page 78: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/78.jpg)
Leukocyte diversity in atherosclerosis.
Klingenberg R , Hansson G K Eur Heart J 2009;30:2838-2844
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: [email protected]
![Page 79: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/79.jpg)
Prognostic role of clinical risk scores and biomarkers of cardiovascular risk.
Kaski J C Eur Heart J 2010;31:274-277
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: [email protected]
![Page 80: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/80.jpg)
Risk modifiers influence atherogenesis through effects on inflammation as reflected by biomarkers of the acute phase response.
Libby P , Crea F Eur Heart J 2010;31:777-783
![Page 81: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/81.jpg)
Framingham Framingham TenTen Year Risk Year Risk
Men Women
![Page 82: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/82.jpg)
Framingham Ten Year RiskFramingham Ten Year Risk
0
![Page 83: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/83.jpg)
Framingham Ten Year RiskFramingham Ten Year Risk
0
3 Non-Smoker
0
![Page 84: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/84.jpg)
Framingham Ten Year RiskFramingham Ten Year Risk
0
3
0HDL = 43
1
![Page 85: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/85.jpg)
Framingham Ten Year RiskFramingham Ten Year Risk
0
3
0
1SBP = 119, untreated
0
4
![Page 86: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/86.jpg)
Framingham Ten Year RiskFramingham Ten Year Risk
0
3
0
1
0
4
![Page 87: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/87.jpg)
ال ايده ال سطح ايده افراد Non HDLNon HDLووLDLLDLسطح افراد در درمختلفمختلف
میزان ریسکوضعیت بیمارLDL هدف
)mg/dl(شروع رژیم
غذایی و فعالیت
شروع دارو
HDL non-
هدف) mg/dl)
وبيماري عروق كرونر ديابت يا چند ريسك
فاكتور قلبي
Very High كمتراز 70
كمتر از ≥70 ≥70 100
بيماري عروق معادالت ياكرونر
آن
High كمتر از100
كمتر از ≥ 100 ≥ 100 130
ريسك فاكتور قلبي 2 ≥و احتمال بيماري كرونر
سال آینده 10در %10-20بين
Moderately High
كمتر از 100
كمتر از ≥ 130 ≥ 130 130
ريسك فاكتور 2 ≥قلبي و احتمال
بيماري كرونر در سال آینده کمتر 10
%10از
Moderate كمتر از130
كمتر از ≥ 160 ≥ 130 160
190كمتر از ≥ 190 ≥ 160 160كمتر از lowيك ريسك فاكتور ويا كمتر
![Page 88: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/88.jpg)
TREATMENTTREATMENT
![Page 89: Dr.Toba kazemi Associate Professor of Cardiology BUMS-BCRC 24Farvardin 1391 Harisson 2012 1983-1991.](https://reader035.fdocuments.net/reader035/viewer/2022062423/5697bfa01a28abf838c956b0/html5/thumbnails/89.jpg)
باتشكر از صبر وحوصله شماwww.bums.ac.ir/heartwww.bums.ac.ir/heart